Research is ongoing on second and third generations of cox 2 inhibitors.
Some of these will be developed specifically for the treatment of cancer. In Ohio
researchers have a third generation cox 2 inhibitor being developed as an anti
cancer therapy and report some success against one type of leukemia and type B
lymphoma.